Following the $22.5 million acquisition of Umeå-based UmanDiagnostics by major US biotech company Quanterix more people are now being hired at its offices in Umeå.
“Demand for our products is extremely high in the global marketplace and we’re probably looking at hiring even more people in the future,” says Niklas Norgren, CEO of UmanDiagnostics.
Acquired by Quanterix
At the end of June 2019 UmanDiagnostics was purchased by its largest customer and partner – US life science tools company Quanterix. Thanks to the acquisition UmanDiagnostics gained access to Quanterix’s marketing and sales department, which resulted in two new appointments being made at the company’s Umeå offices. The two new employees are Charlotta Norman, who will focus on customer support, orders and logistics, and Carola Falk, who will work with research and development.
As part of acquisition negotiations it was agreed UmanDiagnostics would retain its name and remain in Umeå. “That’s why it feels extra rewarding that even at this early stage we can hire new employees. There is huge demand for neurodiagnostic products and with our expanded marketing channels we can now reach an even larger target group of potential customers. We will almost certainly need to hire even more people in the future,” says Niklas Norgren.
The two new appointments brings the total number of staff at UmanDiagnostics to eight. UmanDiagnostics is located at the Umeå Biotech Incubator.
Photo of Charlotta Norman and Carola Falk, UmanDiagnostics